Monograph Details
|
|
Eye Disorders
> Ocular infections
|
|
OCUFLOX |
| Manufacturer |
|
Allergan |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Quinolone. |
| Generic Name |
|
Ofloxacin 0.3%; oph. soln; contains benzalkonium chloride. |
| Indications |
|
Susceptible infections of the conjuctiva and corneal ulcer. |
| Adults and Children |
|
<1 yr: not recommended. ≥1 yr: Conjunctivitis: 1–2 drops every 2–4 hrs for 2 days, then 4 times daily for 5 more days. Corneal ulcer: 1–2 drops every 30 minutes while awake and at 4 hrs & 6 hrs after retiring for sleep for 2 days, then 1–2 drops every 1 hr while awake for days 3 through 7–9, then 1–2 drops 4 times daily through treatment completion. |
| Precautions |
|
Discontinue if superinfection or hypersensitivity occurs. Pregnancy (Cat.C). Nursing mothers: not recommended. |
| Interactions |
|
Possible potentiation of theophylline, caffeine, oral anticoagulants, cyclosporine if systemic absorption occurs. |
| Adverse Reactions |
|
Superinfection, photophobia, lacrimation, transient local reactions including burning, stinging, redness, itching, dry eye; anaphylaxis, Stevens-Johnson syndrome (rare). |
| How Supplied |
|
Soln—5mL |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
